Current
14.2×
5-Year Average
30.3×
All-Time High
160.0×
All-Time Low
6.7×
P/FCF Ratio daily chart for Elevance Health (ELV)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/FCF Ratio for Elevance Health (ELV) from 2002 to 2025
| 2025 | $77.75B | $3.17B | 24.5× | +6.1× | |
| 2024 | $83.92B | $4.55B | 18.4× | +2.2× | |
| 2023 | $109.91B | $6.76B | 16.2× | -0.6× | |
| 2022 | $122.07B | $7.25B | 16.8× | +1.4× | |
| 2021 | $112.07B | $7.28B | 15.4× | +7.2× | |
| 2020 | $78.80B | $9.67B | 8.2× | -7.2× | |
| 2019 | $76.39B | $4.98B | 15.3× | -10.5× | |
| 2018 | $67.59B | $2.62B | 25.8× | +8.8× | |
| 2017 | $57.62B | $3.39B | 17.0× | +2.5× | |
| 2016 | $37.92B | $2.62B | 14.5× | +4.0× | |
| 2015 | $36.43B | $3.48B | 10.5× | -2.1× | |
| 2014 | $33.50B | $2.65B | 12.6× | +1.8× | |
| 2013 | $26.05B | $2.41B | 10.8× | +2.4× | |
| 2012 | $18.47B | $2.20B | 8.4× | +0.7× | |
| 2011 | $21.98B | $2.85B | 7.7× | -14.0× | |
| 2010 | $20.96B | $965.30M | 21.7× | +12.1× | |
| 2009 | $25.71B | $2.66B | 9.7× | +0.1× | |
| 2008 | $20.90B | $2.19B | 9.5× | -2.3× | |
| 2007 | $47.77B | $4.02B | 11.9× | -0.6× | |
| 2006 | $48.14B | $3.85B | 12.5× | -4.3× | |
| 2005 | $52.13B | $3.09B | 16.8× | -13.3× | |
| 2004 | $35.22B | $1.17B | 30.2× | +20.2× | |
| 2003 | $10.36B | $1.03B | 10.0× | -0.0× | |
| 2002 | $8.74B | $867.80M | 10.1× | — |
- 202524.5×
- 202418.4×
- 202316.2×
- 202216.8×
- 202115.4×
- 20208.2×
- 201915.3×
- 201825.8×
- 201717.0×
- 201614.5×
- 201510.5×
- 201412.6×
- 201310.8×
- 20128.4×
- 20117.7×
- 201021.7×
- 20099.7×
- 20089.5×
- 200711.9×
- 200612.5×
- 200516.8×
- 200430.2×
- 200310.0×
- 200210.1×
About P/FCF Ratio at Elevance Health (ELV)
Elevance Health (ELV) P/FCF ratio is 14.2× as of June 5, 2026. The 5-year average is 30.3×. The sector median currently stands at 19.8×. The current ratio is at the 39th percentile of its own 10-year history.
Elevance Health (ELV) historical P/FCF ratio has ranged from a low of 6.7× (2020) to a high of 160.0× (2024) in the available daily series.
The price-to-free-cash-flow (P/FCF) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) free cash flow. It is calculated as market cap ÷ TTM free cash flow, where free cash flow = operating cash flow − capital expenditures. Because FCF cannot be inflated by non-cash accounting items, P/FCF is often considered a cleaner measure of "earnings-power valuation" than P/E — especially for capital-intensive businesses where depreciation diverges from real cash outflows.
Elevance Health P/FCF Ratio by Year
Elevance Health P/FCF Ratio 2025: 24.5×
Elevance Health (ELV) P/FCF ratio in 2025 was 24.5×, expanded from 18.4× the prior year.
Elevance Health P/FCF Ratio 2024: 18.4×
Elevance Health (ELV) P/FCF ratio in 2024 was 18.4×, expanded from 16.2× the prior year.
Elevance Health P/FCF Ratio 2023: 16.2×
Elevance Health (ELV) P/FCF ratio in 2023 was 16.2×, contracted from 16.8× the prior year.
Elevance Health P/FCF Ratio 2022: 16.8×
Elevance Health (ELV) P/FCF ratio in 2022 was 16.8×, expanded from 15.4× the prior year.
Elevance Health P/FCF Ratio 2021: 15.4×
Elevance Health (ELV) P/FCF ratio in 2021 was 15.4×.
Sector peers by P/FCF Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/FCF Ratio — table
Healthcare peers of Elevance Health (ELV), ranked by P/FCF ratio.
| 18.5× | |
| 17.8× | |
| 17.8× | |
| 16.9× | |
| 16.9× | |
| 16.7× | |
| 16.4× | |
| 16.3× | |
| 15.9× | |
| 14.0× | |
| 13.5× | |
| 12.9× | |
| 12.5× | |
| 12.4× | |
| 12.2× | |
| 12.1× | |
| 11.3× | |
| 10.7× | |
| 10.4× | |
| 10.3× | |
| 9.6× | |
| 9.1× | |
| 9.1× | |
| 6.9× | |
| 2.5× |
- 18.5×
- 17.8×
- 16.9×
- 16.7×
- 16.4×
- 13.5×
- 12.9×
- 12.4×
- 10.7×
- 10.3×
- 9.1×
- 9.1×
- 6.9×
- 2.5×
Frequently asked questions
Elevance Health (ELV) Key Financials
Charts, filings, and peer comparison for every metric